Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO

Oscar Health, Inc.

New role as Co-Founder & Advisor to CEO effective June 1, 2026; continues to serve on Board.
Annual base salary set at $370,000; no longer eligible for annual bonus starting 2026.
Will not receive future equity awards; existing equity continues to vest per original terms.
No cash severance or subsidized healthcare upon termination of employment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Mario Schlosser

Co-Founder & Advisor to the CEO

OSCR · Oscar Health, Inc.

Effective: 2026-06-01
Filed: June 2, 2026, 6:31 AM ET

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mario Schlosser changed role as Co-Founder & Advisor to the CEO at Oscar Health, Inc..

Action: transitioned
Role: Co-Founder & Advisor to the CEO

Exact text from the filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

View on SEC.gov

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001568651-26-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.